OcUGT1-Catalyzing Glycodiversification of Steroids through Glucosylation and Transglucosylation Actions

Por Yan-Li Xu, Jian-Qiang Kong
Publicado em 2020-01-01

Neuroprotective effects of monosialotetrahexosylganglioside

Por Ai-ping Xi, Zhong-xin Xu, Feng-li Liu, Yan-li Xu
Publicado em 2015-01-01

LATS2 is De-methylated and Overexpressed in Nasopharyngeal Carcinoma and Predicts Poor Prognosis

Por Zhang, Yan, Hu, Chun-Fang, Chen, Jing, Yan, Li-Xu, Zeng, Yi-Xin, Shao, Jian-Yong
Publicado em 2010

VISTA expression associated with CD8 confers a favorable immune microenvironment and better overall survival in hepatocellular carcinoma

Por Zhang, Ming, Pang, Hua-Jin, Zhao, Wei, Li, Yu-Fa, Yan, Li-Xu, Dong, Zhong-Yi, He, Xiao-Feng
Publicado no BMC Cancer (2018)

Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A

Por Du, Zi-Ming, Hu, Li-Fu, Wang, Hai-Yun, Yan, Li-Xu, Zeng, Yi-Xin, Shao, Jian-Yong, Ernberg, Ingemar
Publicado em 2011

MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis

Por Yan, Li-Xu, Huang, Xiu-Fang, Shao, Qiong, Huang, MA-Yan, Deng, Ling, Wu, Qiu-Liang, Zeng, Yi-Xin, Shao, Jian-Yong
Publicado em 2008

Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma

Por Chen, Jing, Hu, Chun-Fang, Hou, Jing-Hui, Shao, Qiong, Yan, Li-Xu, Zhu, Xiao-Feng, Zeng, Yi-Xin, Shao, Jian-Yong
Publicado em 2010

MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Por Yan, Li-Xu, Liu, Yan-Hui, Luo, Dong-Lan, Zhang, Fen, Cheng, Yu, Luo, Xin-Lan, Xu, Jie, Cheng, Jie, Zhuang, Heng-Guo
Publicado em 2014

Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels

Por Lin, Zi-Ying, Liang, Zhen-Xing, Zhuang, Pei-Lin, Chen, Jie-Wei, Cao, Yun, Yan, Li-Xu, Yun, Jing-Ping, Xie, Dan, Cai, Mu-Yan
Publicado no BMC Cancer (2016)

Methylation-associated silencing of miR-200b facilitates human hepatocellular carcinoma progression by directly targeting BMI1

Por Wu, Wen-rui, Sun, Hong, Zhang, Rui, Yu, Xian-huan, Shi, Xiang-de, Zhu, Man-sheng, Zeng, Hong, Yan, Li-xu, Xu, Lei-bo, Liu, Chao
Publicado no Oncotarget (2016)

Prognostic factors affecting postoperative survival of patients with solitary small hepatocellular carcinoma

Por Cai, Mu-Yan, Wang, Feng-Wei, Li, Chang-Peng, Yan, Li-Xu, Chen, Jie-Wei, Luo, Rong-Zhen, Yun, Jing-Ping, Zeng, Yi-Xin, Xie, Dan
Publicado no Chin J Cancer (2016)

Overexpression of SRC‐3 promotes esophageal squamous cell carcinoma aggressiveness by enhancing cell growth and invasiveness

Por Xu, Fang‐Ping, Liu, Yan‐Hui, Luo, Xin‐Lan, Zhang, Fen, Zhou, Hai‐Yu, Ge, Yan, Liu, Chao, Chen, Jie, Luo, Dong‐Lan, Yan, Li‐Xu, Mei, Ping, Xu, Jie, Zhuang, Heng‐Guo
Publicado no Cancer Med (2016)

Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth

Por Yan, Li Xu, Wu, Qi Nian, Zhang, Yan, Li, Yang Yang, Liao, Ding Zhun, Hou, Jing Hui, Fu, Jia, Zeng, Mu Sheng, Yun, Jing Ping, Wu, Qiu Liang, Zeng, Yi Xin, Shao, Jian Yong
Publicado em 2011

EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer

Por Dong, Zhong-Yi, Zhang, Jia-Tao, Liu, Si-Yang, Su, Jian, Zhang, Chao, Xie, Zhi, Zhou, Qing, Tu, Hai-Yan, Xu, Chong-Rui, Yan, Li-Xu, Li, Yu-Fa, Zhong, Wen-Zhao, Wu, Yi-Long
Publicado no Oncoimmunology (2017)

Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups

Por Zhang, Fen, Yan, Li-Xu, Lin, Su-Xia, Ye, Zi-Yin, Zhuang, Heng-Guo, Yun, Jing-Ping, Lin, Han-Liang, Luo, Dong-Lan, Xu, Fang-Ping, Luo, Xin-Lan, Cheng, Jie, Zhang, Ke-Ping, Liu, Yan-Hui
Publicado em 2013

PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer

Por YAN, LI-XU, LIU, YAN-HUI, XIANG, JIAN-WEN, WU, QI-NIAN, XU, LEI-BO, LUO, XIN-LAN, ZHU, XIAO-LAN, LIU, CHAO, XU, FANG-PING, LUO, DONG-LAN, MEI, PING, XU, JIE, ZHANG, KE-PING, CHEN, JIE
Publicado no Int J Oncol (2015)

Clinical outcomes of advanced non-small-cell lung cancer patients with EGFR mutation, ALK rearrangement and EGFR/ALK co-alterations

Por Lou, Na-Na, Zhang, Xu-Chao, Chen, Hua-Jun, Zhou, Qing, Yan, Li-Xu, Xie, Zhi, Su, Jian, Chen, Zhi-Hong, Tu, Hai-Yan, Yan, Hong-Hong, Wang, Zhen, Xu, Chong-Rui, Jiang, Ben-Yuan, Wang, Bin-Chao, Bai, Xiao-Yan, Zhong, Wen-Zhao, Wu, Yi-Long, Yang, Jin-Ji
Publicado no Oncotarget (2016)